Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2132906108', 'doi': 'https://doi.org/10.1016/j.neurobiolaging.2011.06.019', 'title': 'Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias', 'display_name': 'Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias', 'publication_year': 2012, 'publication_date': '2012-09-01', 'ids': {'openalex': 'https://openalex.org/W2132906108', 'doi': 'https://doi.org/10.1016/j.neurobiolaging.2011.06.019', 'mag': '2132906108', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21821315'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.neurobiolaging.2011.06.019', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S284573', 'display_name': 'Neurobiology of Aging', 'issn_l': '0197-4580', 'issn': ['0197-4580', '1558-1497'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5001945408', 'display_name': 'Fabrizio Gardoni', 'orcid': 'https://orcid.org/0000-0003-4598-5563'}, 'institutions': [{'id': 'https://openalex.org/I189158943', 'display_name': 'University of Milan', 'ror': 'https://ror.org/00wjc7c48', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I189158943']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Fabrizio Gardoni', 'raw_affiliation_strings': ['Dipartimento Scienze Farmacologiche, Università degli Studi di Milano, Milano, Italy'], 'affiliations': [{'raw_affiliation_string': 'Dipartimento Scienze Farmacologiche, Università degli Studi di Milano, Milano, Italy', 'institution_ids': ['https://openalex.org/I189158943']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007094311', 'display_name': 'Carmelo Sgobio', 'orcid': 'https://orcid.org/0000-0002-6282-369X'}, 'institutions': [{'id': 'https://openalex.org/I4210150112', 'display_name': 'Fondazione Santa Lucia', 'ror': 'https://ror.org/05rcxtd95', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210150112', 'https://openalex.org/I4210153126']}, {'id': 'https://openalex.org/I4210153126', 'display_name': 'Istituti di Ricovero e Cura a Carattere Scientifico', 'ror': 'https://ror.org/04tfzc498', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Carmelo Sgobio', 'raw_affiliation_strings': ['Laboratorio di Neurofisiologia, Fondazione Santa Lucia, IRCCS, Rome, Italy'], 'affiliations': [{'raw_affiliation_string': 'Laboratorio di Neurofisiologia, Fondazione Santa Lucia, IRCCS, Rome, Italy', 'institution_ids': ['https://openalex.org/I4210150112', 'https://openalex.org/I4210153126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091250297', 'display_name': 'Valentina Pendolino', 'orcid': 'https://orcid.org/0000-0002-7530-7627'}, 'institutions': [{'id': 'https://openalex.org/I4210150112', 'display_name': 'Fondazione Santa Lucia', 'ror': 'https://ror.org/05rcxtd95', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210150112', 'https://openalex.org/I4210153126']}, {'id': 'https://openalex.org/I4210153126', 'display_name': 'Istituti di Ricovero e Cura a Carattere Scientifico', 'ror': 'https://ror.org/04tfzc498', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Valentina Pendolino', 'raw_affiliation_strings': ['Laboratorio di Neurofisiologia, Fondazione Santa Lucia, IRCCS, Rome, Italy'], 'affiliations': [{'raw_affiliation_string': 'Laboratorio di Neurofisiologia, Fondazione Santa Lucia, IRCCS, Rome, Italy', 'institution_ids': ['https://openalex.org/I4210150112', 'https://openalex.org/I4210153126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088823694', 'display_name': 'Paolo Calabresi', 'orcid': 'https://orcid.org/0000-0003-0326-5509'}, 'institutions': [{'id': 'https://openalex.org/I4210153126', 'display_name': 'Istituti di Ricovero e Cura a Carattere Scientifico', 'ror': 'https://ror.org/04tfzc498', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126']}, {'id': 'https://openalex.org/I4210150112', 'display_name': 'Fondazione Santa Lucia', 'ror': 'https://ror.org/05rcxtd95', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210150112', 'https://openalex.org/I4210153126']}, {'id': 'https://openalex.org/I4210089241', 'display_name': 'Azienda Ospedaliera di Perugia', 'ror': 'https://ror.org/006jktr69', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210089241']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Paolo Calabresi', 'raw_affiliation_strings': ['Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy', 'Laboratorio di Neurofisiologia, Fondazione Santa Lucia, IRCCS, Rome, Italy'], 'affiliations': [{'raw_affiliation_string': 'Laboratorio di Neurofisiologia, Fondazione Santa Lucia, IRCCS, Rome, Italy', 'institution_ids': ['https://openalex.org/I4210153126', 'https://openalex.org/I4210150112']}, {'raw_affiliation_string': 'Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy', 'institution_ids': ['https://openalex.org/I4210089241']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005693249', 'display_name': 'Mónica Di Luca', 'orcid': 'https://orcid.org/0000-0003-2298-615X'}, 'institutions': [{'id': 'https://openalex.org/I189158943', 'display_name': 'University of Milan', 'ror': 'https://ror.org/00wjc7c48', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I189158943']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Monica Di Luca', 'raw_affiliation_strings': ['Dipartimento Scienze Farmacologiche, Università degli Studi di Milano, Milano, Italy'], 'affiliations': [{'raw_affiliation_string': 'Dipartimento Scienze Farmacologiche, Università degli Studi di Milano, Milano, Italy', 'institution_ids': ['https://openalex.org/I189158943']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5003176709', 'display_name': 'Barbara Picconi', 'orcid': 'https://orcid.org/0000-0001-6020-1021'}, 'institutions': [{'id': 'https://openalex.org/I4210150112', 'display_name': 'Fondazione Santa Lucia', 'ror': 'https://ror.org/05rcxtd95', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210150112', 'https://openalex.org/I4210153126']}, {'id': 'https://openalex.org/I4210153126', 'display_name': 'Istituti di Ricovero e Cura a Carattere Scientifico', 'ror': 'https://ror.org/04tfzc498', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126']}], 'countries': ['IT'], 'is_corresponding': True, 'raw_author_name': 'Barbara Picconi', 'raw_affiliation_strings': ['Laboratorio di Neurofisiologia, Fondazione Santa Lucia, IRCCS, Rome, Italy'], 'affiliations': [{'raw_affiliation_string': 'Laboratorio di Neurofisiologia, Fondazione Santa Lucia, IRCCS, Rome, Italy', 'institution_ids': ['https://openalex.org/I4210150112', 'https://openalex.org/I4210153126']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 4, 'corresponding_author_ids': ['https://openalex.org/A5003176709'], 'corresponding_institution_ids': ['https://openalex.org/I4210150112', 'https://openalex.org/I4210153126'], 'apc_list': {'value': 3200, 'currency': 'USD', 'value_usd': 3200, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 3.583, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 66, 'citation_normalized_percentile': {'value': 0.999862, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '33', 'issue': '9', 'first_page': '2138', 'last_page': '2144'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10077', 'display_name': 'Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10077', 'display_name': 'Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10085', 'display_name': "Pathophysiology of Parkinson's Disease", 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11601', 'display_name': 'Neural Interface Technology', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/nmda-receptors', 'display_name': 'NMDA Receptors', 'score': 0.518457}], 'concepts': [{'id': 'https://openalex.org/C67018056', 'wikidata': 'https://www.wikidata.org/wiki/Q414896', 'display_name': 'NMDA receptor', 'level': 3, 'score': 0.79769844}, {'id': 'https://openalex.org/C169760540', 'wikidata': 'https://www.wikidata.org/wiki/Q207011', 'display_name': 'Neuroscience', 'level': 1, 'score': 0.53414696}, {'id': 'https://openalex.org/C2779734285', 'wikidata': 'https://www.wikidata.org/wiki/Q11085', 'display_name': "Parkinson's disease", 'level': 3, 'score': 0.53401095}, {'id': 'https://openalex.org/C2780405171', 'wikidata': 'https://www.wikidata.org/wiki/Q629444', 'display_name': 'Dyskinesia', 'level': 4, 'score': 0.52469176}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.49091083}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.40391216}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.36562124}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.30437797}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.2664449}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.22769833}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.18309581}], 'mesh': [{'descriptor_ui': 'D000978', 'descriptor_name': 'Antiparkinson Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D004409', 'descriptor_name': 'Dyskinesia, Drug-Induced', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D016194', 'descriptor_name': 'Receptors, N-Methyl-D-Aspartate', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D018663', 'descriptor_name': 'Adrenergic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018663', 'descriptor_name': 'Adrenergic Agents', 'qualifier_ui': 'Q000633', 'qualifier_name': 'toxicity', 'is_major_topic': False}, {'descriptor_ui': 'D000704', 'descriptor_name': 'Analysis of Variance', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000978', 'descriptor_name': 'Antiparkinson Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054732', 'descriptor_name': 'Calcium-Calmodulin-Dependent Protein Kinase Type 2', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D054732', 'descriptor_name': 'Calcium-Calmodulin-Dependent Protein Kinase Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004195', 'descriptor_name': 'Disease Models, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000076122', 'descriptor_name': 'Disks Large Homolog 4 Protein', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004409', 'descriptor_name': 'Dyskinesia, Drug-Induced', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D004409', 'descriptor_name': 'Dyskinesia, Drug-Induced', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005786', 'descriptor_name': 'Gene Expression Regulation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005786', 'descriptor_name': 'Gene Expression Regulation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D047908', 'descriptor_name': 'Intracellular Signaling Peptides and Proteins', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D047908', 'descriptor_name': 'Intracellular Signaling Peptides and Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008474', 'descriptor_name': 'Medial Forebrain Bundle', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008474', 'descriptor_name': 'Medial Forebrain Bundle', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': False}, {'descriptor_ui': 'D008474', 'descriptor_name': 'Medial Forebrain Bundle', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D008565', 'descriptor_name': 'Membrane Proteins', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D008565', 'descriptor_name': 'Membrane Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016627', 'descriptor_name': 'Oxidopamine', 'qualifier_ui': 'Q000633', 'qualifier_name': 'toxicity', 'is_major_topic': False}, {'descriptor_ui': 'D016627', 'descriptor_name': 'Oxidopamine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': 'Q000209', 'qualifier_name': 'etiology', 'is_major_topic': False}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017208', 'descriptor_name': 'Rats, Wistar', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016194', 'descriptor_name': 'Receptors, N-Methyl-D-Aspartate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013347', 'descriptor_name': 'Subcellular Fractions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.neurobiolaging.2011.06.019', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S284573', 'display_name': 'Neurobiology of Aging', 'issn_l': '0197-4580', 'issn': ['0197-4580', '1558-1497'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://zenodo.org/record/3421125', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306400562', 'display_name': 'Zenodo (CERN European Organization for Nuclear Research)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I67311998', 'host_organization_name': 'European Organization for Nuclear Research', 'host_organization_lineage': ['https://openalex.org/I67311998'], 'host_organization_lineage_names': ['European Organization for Nuclear Research'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21821315', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.7, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 26, 'referenced_works': ['https://openalex.org/W1783167873', 'https://openalex.org/W1958547196', 'https://openalex.org/W1965564800', 'https://openalex.org/W1966443363', 'https://openalex.org/W1967117930', 'https://openalex.org/W1974629156', 'https://openalex.org/W1975716424', 'https://openalex.org/W1985241009', 'https://openalex.org/W1994911797', 'https://openalex.org/W1996759611', 'https://openalex.org/W2013047529', 'https://openalex.org/W2020177305', 'https://openalex.org/W2027274005', 'https://openalex.org/W2043145448', 'https://openalex.org/W2053473574', 'https://openalex.org/W2053853927', 'https://openalex.org/W2059243765', 'https://openalex.org/W2065460329', 'https://openalex.org/W2102668445', 'https://openalex.org/W2135323430', 'https://openalex.org/W2138074851', 'https://openalex.org/W2140463558', 'https://openalex.org/W2149309211', 'https://openalex.org/W2191356548', 'https://openalex.org/W2340133307', 'https://openalex.org/W3185454048'], 'related_works': ['https://openalex.org/W4238165596', 'https://openalex.org/W3082692937', 'https://openalex.org/W2512971311', 'https://openalex.org/W2315473640', 'https://openalex.org/W2305726828', 'https://openalex.org/W2053877581', 'https://openalex.org/W2051854229', 'https://openalex.org/W2035942308', 'https://openalex.org/W2016080450', 'https://openalex.org/W1993907005'], 'abstract_inverted_index': {'Levodopa': [0], '(L-DOPA)-induced': [1], 'dyskinesias': [2, 101], 'represent': [3, 59], 'the': [4, 9, 42, 51, 62, 66, 77, 80, 83, 98, 107], 'main': [5, 63], 'side': [6], 'effect': [7], 'of': [8, 24, 32, 50, 55, 61, 74, 82, 85, 100, 106, 109], 'therapeutic': [10], 'strategy': [11], 'clinically': [12], 'used': [13], 'in': [14, 34, 41, 71], "Parkinson's": [15], 'disease': [16], '(PD)': [17], 'treatment.': [18], 'The': [19], 'first': [20], 'beneficial': [21], '"honeymoon"': [22], 'phase': [23, 31], 'L-DOPA': [25, 36], 'therapy': [26], 'is': [27], 'followed': [28], 'by': [29, 89], 'a': [30, 91, 104], 'deterioration': [33], 'which': [35], 'administration': [37], 'causes': [38, 64], 'motor': [39], 'fluctuations': [40], 'drug': [43], 'efficacy': [44], '("on-off"': [45], 'state)': [46], 'and': [47, 53], 'dyskinesias.': [48, 75], 'Alterations': [49], 'composition': [52, 84], 'function': [54], 'N-methyl-D-aspartate': [56], '(NMDA)': [57], 'receptor': [58, 88], 'one': [60], 'for': [65], 'striatal': [67], 'synaptic': [68, 86], 'changes': [69], 'described': [70], 'experimental': [72], 'model': [73], 'In': [76], 'present': [78], 'study,': [79], 'modulation': [81], 'NMDA': [87], 'using': [90], 'cell-permeable': [92], 'peptide': [93], 'targeting': [94], 'NR2A': [95], 'subunit': [96], 'during': [97], 'development': [99], 'led': [102], 'to': [103], 'reduction': [105], 'percentage': [108], 'parkinsonian': [110], 'rats': [111], 'developing': [112], 'dyskinetic': [113], 'movements.': [114]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2132906108', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 4}, {'year': 2017, 'cited_by_count': 4}, {'year': 2016, 'cited_by_count': 10}, {'year': 2015, 'cited_by_count': 8}, {'year': 2014, 'cited_by_count': 7}, {'year': 2013, 'cited_by_count': 6}, {'year': 2012, 'cited_by_count': 9}], 'updated_date': '2024-08-31T23:50:13.593426', 'created_date': '2016-06-24'}